CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (NASDAQ: ALKS) today announced the election of David Anstice to the company’s Board of Directors. Mr. Anstice brings more than 30 years of experience serving in executive management positions and leading major global activities in the pharmaceutical industry.
